Kendall Law Group Investigates ATS Medical, Inc. Merger for Shareholders
April 30 2010 - 6:02PM
Business Wire
Kendall Law Group, a national securities firm, is investigating
ATS Medical, Inc. (NASDAQ: ATSI) for shareholders in connection
with the proposed sale of the Company to Medtronic Inc. The firm’s
investigation seeks to determine whether ATS and its Board breached
their fiduciary duties by entering into the agreement without
properly shopping for a deal that would provide better value for
shareholders. If you are an ATS shareholder and would like
additional information about your rights, contact the Kendall Law
Group at 877-744-3728 or by email at
skendall@kendalllawgroup.com.
On April 29, 2010, the companies announced that they had entered
into an agreement for ATS to be acquired by Medtronics for $370
million. According to the agreement, ATS shareholders will receive
$4.00 per share. The agreement includes a $13 million termination
fee, making it unlikely that ATS will solicit other offers.
Kendall Law Group was founded by a former federal judge,
includes a former United States Attorney, prosecutors and
securities lawyers who are experienced in complex securities
litigation. The firm has been counsel in dozens of merger and
acquisition cases nationwide, including some of the largest
transactions in the United States.
Ats Medical (MM) (NASDAQ:ATSI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ats Medical (MM) (NASDAQ:ATSI)
Historical Stock Chart
From Oct 2023 to Oct 2024